Canyam
AI summaries for academic research
Home
Preprint
Subscribe
Favorites
Tools
Analysis
Summary
Not logged in
Back
A
Amalia M. Issa
mcgill university
18
H-index
97
Paper Count
1.9K
Citation Count
0
Related Insights
Subscribe
Published Papers
20
Publication Date
Publication Date
Impact Factor
Citations
What Makes an Early-Phase Study Worth Publishing? A View from the Editor's Desk
Clinical Pharmacology in Drug Development
IF
1.8
2026-02-05
0
PRE
AI
Issa, Amalia M.
Share
Save
What Does an Editor Do in 2025?
Clinical Pharmacology in Drug Development
IF
1.8
2025-11-01
0
PRE
AI
Issa, Amalia M.; Fossler, Michael; Upreti, Vijay V.
Share
Save
Model-Informed Drug Development in Early-Phase Development: Navigating Complexity With Quantitative Clarity
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
IF
0
2025-10-01
0
PRE
AI
Issa, Amalia M.
Share
Save
Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?
GENETICS IN MEDICINE
IF
6.2
2024-02-01
2
OA
AI
Friedman, Jan M.; Bombard, Yvonne; Carleton, Bruce; Issa, Amalia M.; Knoppers, Bartha; Plon, Sharon E.; Rahimzadeh, Vasiliki; V. Relling, Mary; Williams, Marc S.; van Karnebeek, Clara; Vears, Danya; Cornel, Martina C.
Share
Save
Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations (vol 21, pg 542, 2019)
GENETICS IN MEDICINE
IF
6.2
2019-08-01
0
OA
AI
Issa, Amalia M.; Thorogood, Adrian; Joly, Yann; Knoppers, Bartha M.
Share
Save
A RETROSPECTIVE ANALYSIS TO EVALUATE GENOME-BASED INTERVENTIONS IN THE LIFETIME TREATMENT PATHWAY OF COLORECTAL CANCER
VALUE IN HEALTH
IF
6
2019-05-01
0
OA
AI
Chaudhari, V; Issa, A. M.
Share
Save
Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
GENETICS IN MEDICINE
IF
6.2
2019-03-01
6
OA
AI
Issa, Amalia M.; Thorogood, Adrian; Joly, Yann; Knoppers, Bartha M.
Share
Save
The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
IF
3.6
2014-12-05
6
OA
AI
Issa, Amalia M.; Chaudhari, Vivek S.; Marchant, Gary E.
Share
Save
FACTORS INFLUENCING USE OF GENE EXPRESSION PROFILING BY PHYSICIANS FOR BREAST CANCER TREATMENT RECOMMENDATIONS
VALUE IN HEALTH
IF
6
2014-05-01
0
OA
AI
Issa, A. M.; Patil, D.
Share
Save
Reply to Cost Effectiveness of Gene Expression Profiling for Early Stage Breast Cancer A Decision-Analytic Model
CANCER
IF
5.1
2012-06-06
0
PRE
AI
Rajan, Suja S.; Yang, Mo; Issa, Amalia M.
Share
Save
Cost Effectiveness of Gene Expression Profiling for Early Stage Breast Cancer
CANCER
IF
5.1
2012-02-22
63
OA
AI
Yang, Mo; Rajan, Suja; Issa, Amalia M.
Share
Save
The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: a systematic review and quantitative appraisal of the evidence
BRITISH JOURNAL OF OPHTHALMOLOGY
IF
3.5
2010-09-02
13
OA
AI
Foster, William J.; Tufail, Waqas; Issa, Amalia M.
Share
Save
Outlook-biomarkers - Diagnostics and biomarker development: priming the pipeline
NATURE REVIEWS DRUG DISCOVERY
IF
101.8
2006-05-19
105
PRE
AI
Phillips, KA; Van Bebber, S; Issa, AM
Share
Save
Effects of omega-3 fatty acids on cancer risk - A systematic review
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF
55
2006-01-25
423
OA
AI
MacLean, CH; Newberry, SJ; Mojica, WA; Khanna, P; Issa, AM; Suttorp, MJ; Lim, YW; Traina, SB; Hilton, L; Garland, R; Morton, SC
Share
Save
Taking off the white coat: Can family members who are physicians be good surrogate decision-makers?
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
IF
4.5
2002-05-28
3
PRE
AI
Issa, AM
Share
Save
Ethical perspectives on pharmacogenomic profiling in the drug development process
NATURE REVIEWS DRUG DISCOVERY
IF
101.8
2002-04-01
78
PRE
AI
Issa, AM
Share
Save
Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: Emerging ethical issues
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
IF
3.8
2000-12-01
16
OA
AI
Issa, AM; Keyserlingk, EW
Share
Save
Current and future clinical trials for Alzheimer's disease: Evolving ethical concerns
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
IF
3.9
2000-11-01
5
PRE
AI
Issa, AM; Keyserlingk, EW
Share
Save
Ethical considerations in clinical pharmacogenomics research
TRENDS IN PHARMACOLOGICAL SCIENCES
IF
19.9
2000-07-01
61
PRE
AI
Issa, AM
Share
Save
Enzyme activity and protein of multiple forms of choline acetyltransferase: Effects of calyculin A and okadaic acid
NEUROCHEMICAL RESEARCH
IF
3.8
1999-01-01
4
PRE
AI
Issa, AM; Gauthier, S; Collier, B
Share
Save
Research Directions
No research directions
Co-authors
Cooperation Journals
M
Mary V. Relling
H-index: 133 · Papers: 638
S
Serge Gauthier
H-index: 116 · Papers: 1.3K
J
Jan M. Friedman
H-index: 93 · Papers: 537
S
Sharon E. Plon
H-index: 81 · Papers: 430
B
Bartha Maria Knoppers
H-index: 79 · Papers: 718
View more
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}
